Persistent Infection: Clinical Trials

36 trials for Persistent Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

21 completed, 9 unknown, 3 active not recruiting, 2 recruiting. 12 Not applicable, 4 Phase 4, 3 Phase 1, 3 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable12Completed 6, Unknown 3, Active not recruiting 1, Enrolling by invitation 1, Recruiting 1
Phase 44Completed 3, Unknown 1
Phase 13Completed 3
Phase 33Completed 3
Phase 22Completed 2

Follow Persistent Infection: new trials by email Literature Review of Persistent Infection trials Research Report on Persistent Infection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
NWRD09 for Persistent Cervical HPV16 Infection
NWRD09/ Placebo administered by IM injection - Persistent Cervical HPV16 Infection
Not applicableRecruitingNewish Biotech (Wuxi) Co., Ltd.602026-02-102026-07-17
Evaluation of Different Medicaments in the Management of Necrotic Primary Molars by Lesion Sterilization and Tissue Repair
Conventional double antibiotic paste of Metronidazole 500 mg plus Ciprofloxacin 500 mg mixed with propylene glycol, Double antibiotic paste of Metronidazole and Ciprofloxacin loaded chitosan-coated silver nanoparticles, chitosan-coated silver nanoparticles - Pain, Postoperative, Root Resorption
Not applicableEnrolling by invitationAin Shams University1082025-07-012026-09-29
A Study To Evaluate The Safety Of CMTX-101 In People With Cystic Fibrosis
CMTX-101, Placebo - Persistent Infection, Cystic Fibrosis
Phase 1 / Phase 2CompletedClarametyx Biosciences, Inc.432024-06-242026-05-05
Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls
Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Escherichia coli), No intervention - Cervical Intraepithelial Neoplasia, Cervical Cancer
Active not recruitingXiamen University21882024-02-202025-07-31
Susceptibility to Infectious Diseases in Obesity
Observational - Obesity, Type2diabetes
RecruitingAzienda Ospedaliero Universitaria Maggiore della Carita802023-10-012026-09-10
CHILD (Child Health and Infection With Low Density) Malaria
Active case detection using molecular testing (ACDm), Passive case detection using molecular testing (PCDm), Control (standard of care) - Malaria,Falciparum, Malaria
Not applicableCompletedUniversity of California, San Francisco6002023-07-182026-01-29
New Strategies for Assessment of the Persistence of Viable Bacilli in Latent and Active Tuberculosis
Latent Tuberculosis, Persistent Infection
CompletedRegion Skane892021-12-212026-09-29
Single-stage Surgery With Antibiotic-loaded Hydrogel Coated Implants Versus Two Stage Surgery for Secondary Prevention of Complex Chronic Periprosthetic Hip Joint Infection
Defensive Antiadhesive Coating DAC®, Novagenit SRL - Hip Prosthesis Infection
Not applicableActive not recruitingCentre Hospitalier Universitaire de Saint Etienne392021-09-302026-05-06
The Durability of Protection and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female
Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Escherichia coli) - Cervical Intraepithelial Neoplasia, Cervical Cancer
UnknownJun Zhang13392021-04-132023-01-26
Relationships Among Inflammation, Physical and Mental Health in Subjects With Chronic Inflammatory Physical Diseases.
Chronic Infectious Disease, Chronic Skin Disease
CompletedUniversity of Campania Luigi Vanvitelli932021-04-012023-11-22
The Durability of Protection Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female
Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Escherichia coli) - Cervical Intraepithelial Neoplasia, Cervical Cancer
UnknownJun Zhang6472021-03-302023-01-26
Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls (54m)
Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Escherichia coli) - Cervical Intraepithelial Neoplasia, Cervical Cancer
UnknownJun Zhang9792021-02-062023-01-26
Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female
Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Escherichia coli) / Cecolin® - Cervical Intraepithelial Neoplasia, Cervical Cancer
Phase 4CompletedXiamen Innovax Biotech Co., Ltd5402020-05-012022-06-29
The Effectiveness of Hyperpure Chlorine Dioxide and Sodium Hypochlorite Irrigants in Endodontic Retreament in RCT
endodontic desinfection - Persistent Infection, Periapical Lesion
UnknownEniko Vaszine Szabo402019-11-152022-10-31
Clinical Post-operative Assessment of Chronic Signs & Symptoms Related to Infected Primary Molars After Using Rotary Versus Manual Systems in Cleaning the Root Canals
Rotary files - Chronic Infection
Not applicableUnknownCairo University502018-10-012018-09-26
Tenofovir Disoproxil Fumarate in Combination of Hepatitis B Vaccine for Preventing Hepatitis B Vertical Transmission
Tenofovir Disoproxil Fumarate (TDF) 300 mg oral daily. - Hepatitis B Infection, Congenital Malformation
Phase 4UnknownNew Discovery LLC2802018-06-102019-12-12
Cost-effectiveness Evaluation of One Stage Versus Two Stage Exchange for Chronically Infected Total Hip and Total Knee Prostheses
Exchange of total hip or knee arthroplasty on same time, Exchange of total hip or knee arthroplasty in two time - Chronically Infected Total Hip of Knee Prosthesis
Not applicableUnknownUniversity Hospital, Strasbourg, France1002018-05-032018-05-22
Prognostic Impact of Delta-haemolysin Production Deficiency in Staphylococcus Aureus on the Prognosis of Infected Implant Treated by DAIR
Delta-haemolysin - Bone and Joint Infection, Staphylococcus Aureus
UnknownHospices Civils de Lyon1002018-01-012023-04-13
Role of the Host Immunity in the Non-response to Direct Anti-viral Agent (DAA) Therapy
blood drawing - Chronic Hepatitis C
Not applicableCompletedAzienda Ospedaliero-Universitaria di Parma772017-08-302021-07-21
An Open Study to Assess the Safety and Pharmacokinetics of Fluorothyazinone as a Single-Dose Administration or a Treatment Course in Healthy Volunteers
Fluorothyazinone 300 mg, Fluorothyazinone 600 mg, Fluorothyazinone 3900 mg - Healthy Volunteer
Phase 1CompletedGamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation252017-08-102018-07-24

Showing 20 of 36. Sign in to see all of them.

Narrower conditions

Uterine Cervical Dysplasia (9)  ·  Uterine Cervical Neoplasms (8)  ·  Hepatitis B (3)  ·  Viremia (3)  ·  HIV Infections (2)  ·  Hepatitis C, Chronic (2)  ·  Abortion, Habitual (1)  ·  Abortion, Spontaneous (1)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Adenoviridae Infections (1)  ·  Asymptomatic Infections (1)  ·  Bronchiectasis (1)  ·  Chronic Disease (1)  ·  Common Cold (1)

Broader conditions

Disease Attributes (36)  ·  Infections (36)  ·  Pathologic Processes (36)  ·  Pathological Conditions, Signs and Symptoms (36)  ·  Urogenital Diseases (13)  ·  Genital Diseases (12)  ·  Virus Diseases (11)  ·  Communicable Diseases (10)  ·  Female Urogenital Diseases and Pregnancy Complications (10)  ·  Neoplasms (10)  ·  Blood-Borne Infections (9)  ·  Female Urogenital Diseases (9)  ·  Genital Diseases, Female (9)  ·  Neoplasms by Site (9)  ·  Precancerous Conditions (9)

Interventions

Vaccines (5)  ·  Tenofovir (2)  ·  Arthroplasty, Replacement, Knee (1)  ·  Auranofin (1)  ·  Blood Specimen Collection (1)  ·  Ciprofloxacin (1)  ·  Hepatitis B Vaccines (1)  ·  Lamivudine (1)  ·  Maraviroc (1)  ·  Niacinamide (1)  ·  Papillomavirus Vaccines (1)  ·  Propylene Glycol (1)  ·  Sodium Hypochlorite (1)  ·  Standard of Care (1)  ·  Telbivudine (1)

Sponsors

Jun Zhang (5)  ·  New Discovery LLC (2)  ·  Xiamen University (2)  ·  Ain Shams University (1)  ·  Azienda Ospedaliero Universitaria Maggiore della Carita (1)  ·  Azienda Ospedaliero-Universitaria di Parma (1)  ·  Cairo University (1)  ·  Centre Hospitalier Universitaire de Saint Etienne (1)  ·  Clarametyx Biosciences, Inc. (1)  ·  Eniko Vaszine Szabo (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  Federal University of São Paulo (1)  ·  Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation (1)  ·  Hospices Civils de Lyon (1)  ·  Hua Zhang (1)

Countries

China (12)  ·  France (4)  ·  Italy (4)  ·  United States (3)  ·  Brazil (2)  ·  Denmark (1)  ·  Egypt (1)  ·  Germany (1)  ·  Hungary (1)  ·  Israel (1)  ·  Russia (1)  ·  Sweden (1)  ·  Tanzania (1)  ·  United Kingdom (1)

Top investigators

Ting Wu, Ph. D. (6)  ·  Calvin Q Pan, MD (2)  ·  Erhei Dai, MD (2)  ·  Yuemei Hu, Bachelor (2)  ·  Ally Olotu, MD, PhD (1)  ·  Amber D'Souza, PhD (1)  ·  Carlo Ferrari, Dr (1)  ·  David Gorard, Dr (1)  ·  Eleanor Barnes, Dr. (1)  ·  Guorong Han, MD (1)

Results publications

PMID 25378645, PMID 27305192, PMID 31394172, PMID 31420362, PMID 33317695, PMID 33789963, PMID 35022035, PMID 36037823, PMID 37032449, PMID 38294704, PMID 38538037, PMID 39540799, PMID 39670565, PMID 39742565, PMID 40000087, PMID 41407728

NIH funding

2009 (1), R35DE026631 (1), U01AI155315 (1)